![Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in coronary artery disease patients with diabetes mellitus]()
Circulating fibroblast growth factor-23 plasma levels predict adverse cardiovascular outcomes in coronary artery disease patients with diabetes mellitusTuñón, José; Fernández-Fernández, Beatriz; Carda, Rocío; Pello, Ana M.; Cristóbal, Carmen; Tarín, Nieves; Aceña, Álvaro; González-Casaus, María Luisa; Huelmos, Ana; Alonso, Joaquín; Lorenzo, Óscar; González-Parra, Emilio; Hernández-González, Ignacio; Mahíllo-Fernández, Ignacio; López-Bescós, Lorenzo; Egido, Jesús · Diabetes/Metabolism Research and Reviews · 2016